UCLA Broad Stem Cell Research Center
@uclastemcell.bsky.social
Supporting innovation, excellence and the highest ethical standards focused on taking stem cell discoveries from the lab to the patient.
#StemCells #RegenerativeMedicine
#StemCells #RegenerativeMedicine
Pinned
🔬For 20 years, our scientists have been redefining what’s possible in regenerative medicine — trailblazing therapies, transforming lives and shaping the future of human health. Dive into our story: stemcell.ucla.edu/20years
#StemCellScience #RegenerativeMedicine
#StemCellScience #RegenerativeMedicine
Join us on Thursday, December 4 as Dr. Darrell Kotton of Boston University presents, “Pluripotent stem cells to model and treat lung disease” at 12pm in CHS 13-105.
The seminar is open to all UCLA faculty, students & staff! 🐻
Register today: bit.ly/4pg3b5E
The seminar is open to all UCLA faculty, students & staff! 🐻
Register today: bit.ly/4pg3b5E
November 20, 2025 at 7:03 PM
Join us on Thursday, December 4 as Dr. Darrell Kotton of Boston University presents, “Pluripotent stem cells to model and treat lung disease” at 12pm in CHS 13-105.
The seminar is open to all UCLA faculty, students & staff! 🐻
Register today: bit.ly/4pg3b5E
The seminar is open to all UCLA faculty, students & staff! 🐻
Register today: bit.ly/4pg3b5E
Reposted by UCLA Broad Stem Cell Research Center
El #CNIOStopCancer acoge el encuentro internacional #CFM_MolCellAging en el que 20 ponentes están exponiendo los últimos avances en el estudio de las bases biológicas del envejecimiento. Abordan el papel de las células madre, los telómeros, el metabolismo o el sistema inmunitario
November 18, 2025 at 4:14 PM
El #CNIOStopCancer acoge el encuentro internacional #CFM_MolCellAging en el que 20 ponentes están exponiendo los últimos avances en el estudio de las bases biológicas del envejecimiento. Abordan el papel de las células madre, los telómeros, el metabolismo o el sistema inmunitario
Lab tours. Live demos. Real talk with scientists. Students from South Gate High School got an inside look at UCLA's breakthrough research in medicine and disease treatment. Their curiosity and questions brought so much energy to our labs! 🔬🧬🧫
November 18, 2025 at 12:25 AM
Lab tours. Live demos. Real talk with scientists. Students from South Gate High School got an inside look at UCLA's breakthrough research in medicine and disease treatment. Their curiosity and questions brought so much energy to our labs! 🔬🧬🧫
Gene therapy pioneer Dr. Donald Kohn talks to CNN about companies developing gene therapies to help the body make more GLP-1: “There is promise, but much more data would be needed to consider human clinical trials, as it likely would be irreversible,” he said.
www.cnn.com/2025/11/04/h...
www.cnn.com/2025/11/04/h...
The race is on to turn your body into a GLP-1 factory | CNN
People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their cells into tiny factories that churn out a protein that is essentially the acti...
www.cnn.com
November 7, 2025 at 7:52 PM
Gene therapy pioneer Dr. Donald Kohn talks to CNN about companies developing gene therapies to help the body make more GLP-1: “There is promise, but much more data would be needed to consider human clinical trials, as it likely would be irreversible,” he said.
www.cnn.com/2025/11/04/h...
www.cnn.com/2025/11/04/h...
Reposted by UCLA Broad Stem Cell Research Center
What a fantastic way to kick off #CSStemCells2025—delegates and speakers enjoyed a scenic hike to the Hollywood Sign before diving into the latest in stem cell research! #WelcometoLA CedarsSinai @uclastemcell.bsky.social @cp-cellstemcell.bsky.social @cp-cellrepmed.bsky.social
November 3, 2025 at 6:17 PM
What a fantastic way to kick off #CSStemCells2025—delegates and speakers enjoyed a scenic hike to the Hollywood Sign before diving into the latest in stem cell research! #WelcometoLA CedarsSinai @uclastemcell.bsky.social @cp-cellstemcell.bsky.social @cp-cellrepmed.bsky.social
Making clones in the lab this Halloween - what can be spookier?! Happy Halloween from the BSCRC! 🎃
October 31, 2025 at 11:29 PM
Making clones in the lab this Halloween - what can be spookier?! Happy Halloween from the BSCRC! 🎃
Reposted by UCLA Broad Stem Cell Research Center
🔔 Very last call for #CFM_MolCellAging! 🔔
📅Next Monday, 3, is the last day to register at : http://bit.ly/4kOyYch
A full program of cutting-edge science on aging at the molecular and cellular level
Organized by @efeyanlab.bsky.social , Maria Blasco and Thomas_RandO @uclastemcell.bsky.social
📅Next Monday, 3, is the last day to register at : http://bit.ly/4kOyYch
A full program of cutting-edge science on aging at the molecular and cellular level
Organized by @efeyanlab.bsky.social , Maria Blasco and Thomas_RandO @uclastemcell.bsky.social
October 31, 2025 at 11:36 AM
🔔 Very last call for #CFM_MolCellAging! 🔔
📅Next Monday, 3, is the last day to register at : http://bit.ly/4kOyYch
A full program of cutting-edge science on aging at the molecular and cellular level
Organized by @efeyanlab.bsky.social , Maria Blasco and Thomas_RandO @uclastemcell.bsky.social
📅Next Monday, 3, is the last day to register at : http://bit.ly/4kOyYch
A full program of cutting-edge science on aging at the molecular and cellular level
Organized by @efeyanlab.bsky.social , Maria Blasco and Thomas_RandO @uclastemcell.bsky.social
Mark your calendars for Thursday, November 6 as Dr. Konrad Hochedlinger of Harvard University presents, “Investigating mechanisms of cell identity in tissue homeostasis and disease” at 12pm in CHS 13-105.
Register today: bit.ly/4oqWBt5
Register today: bit.ly/4oqWBt5
October 30, 2025 at 10:00 PM
Mark your calendars for Thursday, November 6 as Dr. Konrad Hochedlinger of Harvard University presents, “Investigating mechanisms of cell identity in tissue homeostasis and disease” at 12pm in CHS 13-105.
Register today: bit.ly/4oqWBt5
Register today: bit.ly/4oqWBt5
Reposted by UCLA Broad Stem Cell Research Center
From IGI Affiliate & gene-therapy pioneer Don Kohn ⬇️
A new study in @nejm.org reports that an investigational gene therapy restored immune function in 9 children with LAD-I, a rare & life-threatening immune disorder. Those children are now living symptom-free 2 years after treatment in clinical trials co-led by Dr. Donald Kohn at UCLA.
October 28, 2025 at 10:08 PM
From IGI Affiliate & gene-therapy pioneer Don Kohn ⬇️
UCLA researchers have developed a novel therapy that could fundamentally change the treatment plan for triple-negative breast cancer. This CAR-NKT cell therapy could attack tumors from multiple fronts while dismantling their protective shields.
stemcell.ucla.edu/news/ucla-sc...
stemcell.ucla.edu/news/ucla-sc...
UCLA scientists develop one-product-fits-all immunotherapy for breast cancer
Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main targets that make other types of breast cancers more treatable with powerful ther...
stemcell.ucla.edu
October 22, 2025 at 7:07 PM
UCLA researchers have developed a novel therapy that could fundamentally change the treatment plan for triple-negative breast cancer. This CAR-NKT cell therapy could attack tumors from multiple fronts while dismantling their protective shields.
stemcell.ucla.edu/news/ucla-sc...
stemcell.ucla.edu/news/ucla-sc...
A blood stem cell gene therapy co-developed by UCLA's Dr. Donald Kohn restored immune function in 59 of 62 children with ADA-SCID, a rare and fatal immune disorder, with no serious complications reported. #ResearchPowersProgress
stemcell.ucla.edu/news/gene-th...
stemcell.ucla.edu/news/gene-th...
Gene therapy delivers lasting immune protection in children with rare disorder
An experimental gene therapy developed by researchers at UCLA, University College London and Great Ormond Street Hospital has restored and maintained immune system function in 59 of 62 children born w...
stemcell.ucla.edu
October 15, 2025 at 11:12 PM
A blood stem cell gene therapy co-developed by UCLA's Dr. Donald Kohn restored immune function in 59 of 62 children with ADA-SCID, a rare and fatal immune disorder, with no serious complications reported. #ResearchPowersProgress
stemcell.ucla.edu/news/gene-th...
stemcell.ucla.edu/news/gene-th...
Ever wondered what makes stem cells so special? 🧫🔬
Stop by an interactive stem cell research exhibit at Powell Library to learn about the science that’s rewriting the future of human health.
#StemCellAwarenessDay #ResearchPowersProgress
Stop by an interactive stem cell research exhibit at Powell Library to learn about the science that’s rewriting the future of human health.
#StemCellAwarenessDay #ResearchPowersProgress
October 9, 2025 at 5:35 PM
Ever wondered what makes stem cells so special? 🧫🔬
Stop by an interactive stem cell research exhibit at Powell Library to learn about the science that’s rewriting the future of human health.
#StemCellAwarenessDay #ResearchPowersProgress
Stop by an interactive stem cell research exhibit at Powell Library to learn about the science that’s rewriting the future of human health.
#StemCellAwarenessDay #ResearchPowersProgress
The FDA has approved Phase I clinical trials for a groundbreaking heart tissue regeneration drug developed by UCLA cardiologists — funded entirely by taxpayer dollars. #ResearchPowersProgress
bit.ly/4gVh6eq
bit.ly/4gVh6eq
FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials
The body’s tissues can get injured in many ways, but while some injuries heal perfectly, others don’t heal at all. A cut in the skin, for example, usually heals all on its own, while internal organs, ...
bit.ly
October 6, 2025 at 6:52 PM
The FDA has approved Phase I clinical trials for a groundbreaking heart tissue regeneration drug developed by UCLA cardiologists — funded entirely by taxpayer dollars. #ResearchPowersProgress
bit.ly/4gVh6eq
bit.ly/4gVh6eq
Our center director, Dr. Thomas Rando, is among the 13 distinguished researchers who have joined the Stem Cell Reports Editorial Board! 📖
October 3, 2025 at 5:19 PM
Our center director, Dr. Thomas Rando, is among the 13 distinguished researchers who have joined the Stem Cell Reports Editorial Board! 📖
After decades developing a proven gene therapy for ADA-SCID,
UCLA's Dr. Donald Kohn talks to @nytimes.com about his new mission: getting the life-saving therapy to the patients and families who've been waiting years. #ResearchPowersProgress
www.nytimes.com/2025/09/22/h...
UCLA's Dr. Donald Kohn talks to @nytimes.com about his new mission: getting the life-saving therapy to the patients and families who've been waiting years. #ResearchPowersProgress
www.nytimes.com/2025/09/22/h...
These Patients Got the Cure. Then It Went Away.
www.nytimes.com
October 2, 2025 at 5:04 PM
After decades developing a proven gene therapy for ADA-SCID,
UCLA's Dr. Donald Kohn talks to @nytimes.com about his new mission: getting the life-saving therapy to the patients and families who've been waiting years. #ResearchPowersProgress
www.nytimes.com/2025/09/22/h...
UCLA's Dr. Donald Kohn talks to @nytimes.com about his new mission: getting the life-saving therapy to the patients and families who've been waiting years. #ResearchPowersProgress
www.nytimes.com/2025/09/22/h...
UCLA scientists have received $4.7 million in @cirmnews.bsky.social grants to advance stem cell-based treatments for female-specific diseases and childhood leukemia in Down syndrome.
Congratulations to Dr. Kathrin Plath and Dr. Hanna Mikkola!
bit.ly/42ekrPN
#ResearchPowersProgress
Congratulations to Dr. Kathrin Plath and Dr. Hanna Mikkola!
bit.ly/42ekrPN
#ResearchPowersProgress
UCLA scientists receive $4.7 million in CIRM grants to advance novel stem cell-based treatments for female-specific diseases and leukemia in Down syndrome
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received $4.7 million in grants from the California Institute for Regenerative Medicine, the...
bit.ly
September 29, 2025 at 10:53 PM
UCLA scientists have received $4.7 million in @cirmnews.bsky.social grants to advance stem cell-based treatments for female-specific diseases and childhood leukemia in Down syndrome.
Congratulations to Dr. Kathrin Plath and Dr. Hanna Mikkola!
bit.ly/42ekrPN
#ResearchPowersProgress
Congratulations to Dr. Kathrin Plath and Dr. Hanna Mikkola!
bit.ly/42ekrPN
#ResearchPowersProgress
Join us on Thursday, October 2 as Dr. Alex Shcheglovitov of the University of Utah presents, "Neural rosette-based brain organoids: A controlled stem cell-derived model to study human neurodevelopment and disease” at 12pm in CHS 13-105.
Register today: ➡️ bit.ly/3W7cXKK
Register today: ➡️ bit.ly/3W7cXKK
September 25, 2025 at 11:23 PM
Join us on Thursday, October 2 as Dr. Alex Shcheglovitov of the University of Utah presents, "Neural rosette-based brain organoids: A controlled stem cell-derived model to study human neurodevelopment and disease” at 12pm in CHS 13-105.
Register today: ➡️ bit.ly/3W7cXKK
Register today: ➡️ bit.ly/3W7cXKK
A UCLA study from the lab of Melody Li reveals how some mosquito-borne viruses, including chikungunya, breach the blood-brain barrier — and points toward new ways of stopping them. 🦟🧠
#ResearchPowersProgress
stemcell.ucla.edu/news/headspa...
#ResearchPowersProgress
stemcell.ucla.edu/news/headspa...
Headspace invaders: How mosquito-borne viruses breach the brain’s defenses
Mosquito-borne viruses can cause more than fevers and joint pain. In severe cases, they invade the brain, leading to seizures, encephalitis, lasting memory loss and sometimes death. But thanks to a ne...
stemcell.ucla.edu
September 25, 2025 at 9:15 PM
A UCLA study from the lab of Melody Li reveals how some mosquito-borne viruses, including chikungunya, breach the blood-brain barrier — and points toward new ways of stopping them. 🦟🧠
#ResearchPowersProgress
stemcell.ucla.edu/news/headspa...
#ResearchPowersProgress
stemcell.ucla.edu/news/headspa...
Reposted by UCLA Broad Stem Cell Research Center
Researchers at @uclastemcell.bsky.social & @dgsomucla.bsky.social created the first human hippocampal #assembloid model, which can be used to study epilepsy as well as neurodevelopmental, neurodegenerative, and other brain disorders.
stemcell.ucla.edu/news/ucla-re...
#devbio #neuroskyence 🧪
stemcell.ucla.edu/news/ucla-re...
#devbio #neuroskyence 🧪
UCLA researchers find how epilepsy genes disrupt different brain regions using stem cell models
For families of children with severe epilepsy, controlling seizures is often just the beginning of their challenges. Even in cases where powerful medications can reduce seizures, many children continu...
stemcell.ucla.edu
September 19, 2025 at 11:50 AM
Researchers at @uclastemcell.bsky.social & @dgsomucla.bsky.social created the first human hippocampal #assembloid model, which can be used to study epilepsy as well as neurodevelopmental, neurodegenerative, and other brain disorders.
stemcell.ucla.edu/news/ucla-re...
#devbio #neuroskyence 🧪
stemcell.ucla.edu/news/ucla-re...
#devbio #neuroskyence 🧪
A UCLA research team led by Dr. Donald Kohn is developing a one-time stem cell gene therapy treatment for deadly blood disorder alpha thalassemia major that’s potentially curative.
#ResearchPowersProgress: newsroom.ucla.edu/releases/ste...
#ResearchPowersProgress: newsroom.ucla.edu/releases/ste...
September 18, 2025 at 6:28 PM
A UCLA research team led by Dr. Donald Kohn is developing a one-time stem cell gene therapy treatment for deadly blood disorder alpha thalassemia major that’s potentially curative.
#ResearchPowersProgress: newsroom.ucla.edu/releases/ste...
#ResearchPowersProgress: newsroom.ucla.edu/releases/ste...
Reposted by UCLA Broad Stem Cell Research Center
CIRM-funded @uclastemcell.bsky.social researchers reprogrammed blood #StemCells to produce #cancer-targeting T cells—offering a renewable path for immunotherapy. Early results are promising for treatment-resistant tumors.
#BlueskyBiotech
#BlueskyBiotech
UCLA scientists reprogram stem cells to create renewable cancer-fighting T cells
In a first-of-its-kind clinical trial, UCLA scientists have shown it’s possible to reprogram a patient’s blood-forming stem cells to generate a continuous supply of functional T cells, the immune syst...
stemcell.ucla.edu
September 10, 2025 at 4:20 PM
CIRM-funded @uclastemcell.bsky.social researchers reprogrammed blood #StemCells to produce #cancer-targeting T cells—offering a renewable path for immunotherapy. Early results are promising for treatment-resistant tumors.
#BlueskyBiotech
#BlueskyBiotech
Congratulations to Dr. Dawn Ward of the UCLA Human Gene and Cell Therapy Facility for receiving a G-Rex Grant that will support production of a novel iNKT cell therapy developed by Dr. Lili Yang! 🦠🧪🧫
🔗 bit.ly/46bUIso
#ResearchPowersProgress
🔗 bit.ly/46bUIso
#ResearchPowersProgress
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
/PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that eight...
bit.ly
September 12, 2025 at 12:28 AM
Congratulations to Dr. Dawn Ward of the UCLA Human Gene and Cell Therapy Facility for receiving a G-Rex Grant that will support production of a novel iNKT cell therapy developed by Dr. Lili Yang! 🦠🧪🧫
🔗 bit.ly/46bUIso
#ResearchPowersProgress
🔗 bit.ly/46bUIso
#ResearchPowersProgress
Using #stemcell models, @ucla.edu scientists find how epilepsy genes disrupt different brain regions. The study establishes the first hippocampal assembloid model, creating a new platform for studying epilepsy, autism and Alzheimer’s disease.
#ResearchPowersProgress 🔗 bit.ly/3JTyjbR
#ResearchPowersProgress 🔗 bit.ly/3JTyjbR
September 8, 2025 at 5:02 PM
Using #stemcell models, @ucla.edu scientists find how epilepsy genes disrupt different brain regions. The study establishes the first hippocampal assembloid model, creating a new platform for studying epilepsy, autism and Alzheimer’s disease.
#ResearchPowersProgress 🔗 bit.ly/3JTyjbR
#ResearchPowersProgress 🔗 bit.ly/3JTyjbR
New in @cp-cellreports.bsky.social ➡️ bit.ly/4mVlAUO
Aging is associated with chronic inflammation and altered blood cell production, reducing immunity and increasing blood cancer risk. Dr. Jennifer Chia and team find that chronic inflammation plays two distinct roles in blood system aging.
Aging is associated with chronic inflammation and altered blood cell production, reducing immunity and increasing blood cancer risk. Dr. Jennifer Chia and team find that chronic inflammation plays two distinct roles in blood system aging.
September 5, 2025 at 6:49 PM
New in @cp-cellreports.bsky.social ➡️ bit.ly/4mVlAUO
Aging is associated with chronic inflammation and altered blood cell production, reducing immunity and increasing blood cancer risk. Dr. Jennifer Chia and team find that chronic inflammation plays two distinct roles in blood system aging.
Aging is associated with chronic inflammation and altered blood cell production, reducing immunity and increasing blood cancer risk. Dr. Jennifer Chia and team find that chronic inflammation plays two distinct roles in blood system aging.
Reposted by UCLA Broad Stem Cell Research Center
👥#CFM_MolCellAging: In the second session, we'll hear talks on cancer and aging from:
Thomas_Rando @uclastemcell.bsky.social
@efeyanlab.bsky.social at #CNIOStopCancer
@EileenWhitePhD @rutgerscancer.bsky.social
Register at: bit.ly/4kOyYch
🤝With support of @caixaresearch.bsky.social
Thomas_Rando @uclastemcell.bsky.social
@efeyanlab.bsky.social at #CNIOStopCancer
@EileenWhitePhD @rutgerscancer.bsky.social
Register at: bit.ly/4kOyYch
🤝With support of @caixaresearch.bsky.social
September 4, 2025 at 8:02 AM
👥#CFM_MolCellAging: In the second session, we'll hear talks on cancer and aging from:
Thomas_Rando @uclastemcell.bsky.social
@efeyanlab.bsky.social at #CNIOStopCancer
@EileenWhitePhD @rutgerscancer.bsky.social
Register at: bit.ly/4kOyYch
🤝With support of @caixaresearch.bsky.social
Thomas_Rando @uclastemcell.bsky.social
@efeyanlab.bsky.social at #CNIOStopCancer
@EileenWhitePhD @rutgerscancer.bsky.social
Register at: bit.ly/4kOyYch
🤝With support of @caixaresearch.bsky.social